XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.3
EQUITY AND NONCONTROLLING INTERESTS (Tables)
 9 Months Ended
Sep. 28, 2024
Equity [Abstract]  
Schedule of Reconciliation of the Numerator and Denominator in the Computations of the Basic and Diluted Earnings Per Share
The following table reconciles the numerator and denominator in the computations of basic and diluted earnings per share:
Three Months EndedNine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
(in thousands)
Numerator:  
Net income$70,295 $88,021 $239,038 $291,418 
Less: Net income attributable to noncontrolling interests638 632 2,340 3,878 
Net income attributable to Charles River Laboratories International Inc.69,657 87,389 236,698 287,540 
Calculation of net income per share attributable to Charles River Laboratories International Inc. common shareholders
Net income attributable to Charles River Laboratories International Inc.$69,657 $87,389 $236,698 $287,540 
Less: Adjustment of redeemable noncontrolling interest (1)
379 — 1,081 — 
Less: Incremental dividends attributable to noncontrolling interest holders (2)
599 — 9,621 — 
Net income available to Charles River Laboratories International Inc. common shareholders$68,679 $87,389 $225,996 $287,540 
Denominator:  
Weighted-average shares outstanding - Basic51,394 51,283 51,461 51,199 
Effect of dilutive securities:
Stock options, restricted stock units and performance share units189 324 252 294 
Weighted-average shares outstanding - Diluted51,583 51,607 51,713 51,493 
Anti-dilutive common stock equivalents (3)
746 588 505 514 
(1) Represents adjustments of redeemable noncontrolling interest that impact retained earnings.
(2) Represents incremental declared and undeclared dividends attributable to Noveprim noncontrolling interest holders who are entitled to preferential dividends for fiscal year 2024.
(3) These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.
Schedule of Accumulated Other Comprehensive Income (Loss)
Changes to each component of accumulated other comprehensive income (loss), net of income taxes, are as follows:
Foreign Currency Translation Adjustment
and Other 		Pension and Other Post-Retirement Benefit PlansNet Unrealized (Loss) Gain on Cash Flow HedgeTotal
(in thousands)
December 30, 2023$(149,999)$(47,167)$739 $(196,427)
Other comprehensive income (loss) before reclassifications
4,054 1,038 (688)4,404 
Net current period other comprehensive income (loss)
4,054 1,038 (688)4,404 
Income tax expense (benefit)757 256 (165)848 
September 28, 2024$(146,702)$(46,385)$216 $(192,871)